Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,840,470 papers from all fields of science
Search
Sign In
Create Free Account
7-hydroxystaurosporine
Known as:
8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo[a, g]cyclonona[cde] Trinden-1-one, 2,3,9,10,11, 12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)
, 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one, 2,3,9,10,11,12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-
, 7-hydroxy-staurosporine
Expand
A synthetic derivative of staurosporine with antineoplastic activity. 7-hydroxystaurosporine inhibits many phosphokinases, including the serine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Broader (3)
Antineoplastic Agents
Protein Kinase Inhibitors
Staurosporine
CHEK1 protein, human
Cyclin-Dependent Kinases
NCIt Antineoplastic Agent Terminology
Negative Regulation of G1 to S Transition
Expand
Narrower (2)
UCN 01
UCN 02
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Phase I and Pharmacokinetic Study of 7-Hydroxystaurosporine and Carboplatin in Advanced Solid Tumors
M. Edelman
,
K. Bauer
,
Suhlan Wu
,
Ruth Smith
,
Sonia Bisacia
,
J. Dancey
Clinical Cancer Research
2007
Corpus ID: 1115181
Purpose: Based on preclinical data showing synergy between 7-hydroxystaurosporine (UCN-01) and platinum agents, a phase I trial…
Expand
Highly Cited
2007
Highly Cited
2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation.
Yun Dai
,
P. Khanna
,
Shuang Chen
,
X. Pei
,
P. Dent
,
S. Grant
Blood
2007
Corpus ID: 2871890
Interactions between UCN-01 and HMG-CoA reductase inhibitors (ie, statins) have been examined in human leukemia and myeloma cells…
Expand
Highly Cited
2005
Highly Cited
2005
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
J. Kortmansky
,
M. Shah
,
+12 authors
G. Schwartz
Journal of Clinical Oncology
2005
Corpus ID: 27546440
PURPOSE Preclinical studies indicate that the cyclin-dependent kinase and protein kinase C inhibitor 7-hydroxystaurosporine (UCN…
Expand
Highly Cited
2004
Highly Cited
2004
7-Hydroxystaurosporine (UCN-01) Inhibition of Akt Thr308 but not Ser473 Phosphorylation
S. Kondapaka
,
M. Zarnowski
,
Dena R. Yver
,
E. Sausville
,
S. Cushman
Clinical Cancer Research
2004
Corpus ID: 10852059
7-Hydroxystaurosporine (UCN-01) infused for 72 hours by continuous i.v. infusion induced insulin resistance during phase I…
Expand
Highly Cited
2002
Highly Cited
2002
Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation*
Ethan A. Kohn
,
Nicola D Ruth
,
Mary Kay Brown
,
M. Livingstone
,
A. Eastman
Journal of Biological Chemistry
2002
Corpus ID: 43612817
DNA damage causes cell cycle arrest in G1, S, or G2 to prevent replication on damaged DNA or to prevent aberrant mitosis. The G1…
Expand
Highly Cited
2002
Highly Cited
2002
Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
V. Patel
,
T. Lahusen
,
+7 authors
A. Senderowicz
Clinical Cancer Research
2002
Corpus ID: 15569732
Altered and deregulated cyclin-dependent kinase (cdk) activity is now believed to play a major role in the pathogenesis of head…
Expand
Highly Cited
2001
Highly Cited
2001
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms.
E. Sausville
,
S. Arbuck
,
+12 authors
A. Senderowicz
Journal of Clinical Oncology
2001
Corpus ID: 29370519
PURPOSE To define the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of the novel protein kinase inhibitor, UCN-01…
Expand
2000
2000
Protein Kinase C ζ Isoform is Critical for Proliferation in Human Glioblastoma Cell Lines
A. Donson
,
A. Banerjee
,
F. Gamboni‐Robertson
,
J. Fleitz
,
N. Foreman
Journal of Neuro-Oncology
2000
Corpus ID: 6792291
Previous studies have confirmed that proliferation in glioblastoma cell lines can be blocked by non-isoform specific protein…
Expand
2000
2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.
Wyndham H. Wilson
,
L. Sorbara
,
+8 authors
Anne Monks
Clinical Cancer Research
2000
Corpus ID: 16871076
Emerging evidence suggests that apoptosis is an important mechanism of tumor cell death from antineoplastic therapy. 7…
Expand
1993
1993
Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
K. Miyamoto
,
K. Inoko
,
+4 authors
M. Koyama
Cancer Research
1993
Corpus ID: 20164603
The effects of a newly synthesized compound, N-ethoxycarbonyl-7-oxo-staurosporine (NA-382), on multidrug resistance in tumor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE